CROI 2019 Program and Conference Information

Oral Sessions

Themed Discussion TD-02 STRUCTURE AND LOCATION OF PROVIRUSES ON ART Room 606-609 Themed Discussion Leader Sarah Palmer, The Westmead Institute for Medical Research, Westmead, NSW, Australia 338 AMETHOD TO DETERMINE BOTH THE INTEGRATION SITES AND SEQUENCES OF HIV-1 PROVIRUSES

1:30 PM - 2:30 PM

Sean Patro, Leah D. Brandt, Michael J. Bale, Elias K. Halvas, Michele Sobolewski, Jenna Hasson, Aurelie Niyongabo, Xiaolin Wu, Shuang Guo, Steven G. Deeks, Stephen H. Hughes, John M. Coffin, Jason W. Rausch, John W. Mellors, Mary F. Kearney DISTINCT CHROMOSOMAL POSITIONS OF INTACT HIV-1 PROVIRUSES Kevin Einkauf, Guinevere Q. Lee, Ce Gao, Radwa Sharaf, Xiaoming Sun, Stephane Hua, Samantha M. Chen, Chenyang Jiang, Xiaodong Lian, Fatema Z. Chowdhury, Eric Rosenberg, Tae-Wook Chun, Jonathan Z. Li, Xu G. Yu, Mathias Lichterfeld RELATIONSHIP BETWEEN INTACT HIV-1 PROVIRUSES AND PLASMA REBOUNDVIRUSES Ching-Lan Lu, Joy A. Pai, Lilian Nogueira, Pilar Mendoza, Marina Caskey, Mila Jankovic, Michel Nussenzweig LANDSCAPE OF HIV-1 INTEGRATION SITES IN LYMPHOID TISSUE FROMART-TREATED INDIVIDUALS Vincent H. Wu, Christopher L. Nobles, Leticia Kuri Cervantes, Perla Del Río-Estrada, Gustavo Reyes-Terán, Frederic Bushman, Michael R. Betts GENETIC AND AGE DISTRIBUTION OF LATENT HIV SEQUENCES IN CD4+T-CELL SUBSETS Rachel Miller, Bradley R. Jones, Olivia Tsai, Bemuluyigza Baraki, Natalie Kinloch, Hanwei Sudderuddin, Hawley Rigsby, Art Poon, Rémi Fromentin, Nicolas Chomont, Jeffrey Joy, Zabrina Brumme

339

340

341

Oral Sessions • Tuesday

342

Themed Discussion TD-03 LET'S CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE Room 6C Themed Discussion Leader Rodolphe Garraffo, Université de Nice-Sophia-Antipolis, Hôpital Pasteur, CHU de Nice, Nice, France 461 PI DRUG-LEVEL TESTING AS A SCREENING TOOL FOR DRUG RESISTANCE IN 2ND-LINE ART FAILURE

1:30 PM - 2:30 PM

Lucas E. Hermans, Kim Steegen, Rob ter Heine, Rob Schuurman, Hugo Tempelman, Robert Moraba, Erik Maarseveen, Taryn Pillay, Derryn Legg- Esilva, Jonathan M. Schapiro, David M. Burger, Sergio Carmona, Annemarie Wensing PLASMA EFV AND TFV VS DRIED BLOOD SPOT TFV-DP TO PREDICT VIRAL SUPPRESSION INWOMEN Tamsin K. Phillips, Phumla Sinxadi, Elaine J. Abrams, Allison Zerbe, Nai-Chung Hu, Yolanda Gomba, Kirsty Brittain, Jennifer Norman, Lubbe Wiesner, Landon Myer, Gary Maartens

462

CROI 2019 37